Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.13 USD | +0.90% | +1.65% | -8.78% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 2.47B | Sales 2025 * | 2.86B | Capitalization | 3.43B |
---|---|---|---|---|---|
Net income 2024 * | 19M | Net income 2025 * | 69M | EV / Sales 2024 * | 1.55 x |
Net Debt 2024 * | 391M | Net Debt 2025 * | 272M | EV / Sales 2025 * | 1.29 x |
P/E ratio 2024 * |
1,168
x | P/E ratio 2025 * |
62
x | Employees | 4,700 |
Yield 2024 * |
0.9% | Yield 2025 * |
0.84% | Free-Float | 94.57% |
Latest transcript on Evolent Health, Inc.
1 day | +0.90% | ||
1 week | +1.65% | ||
Current month | -8.11% | ||
1 month | -7.01% | ||
3 months | -2.87% | ||
6 months | +13.31% | ||
Current year | -8.78% |
Managers | Title | Age | Since |
---|---|---|---|
Seth Blackley
FOU | Founder | 45 | 11-07-31 |
Dan McCarthy
PSD | President | - | 22-09-14 |
Jessica Somers
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Grua
BRD | Director/Board Member | 70 | 20-01-31 |
Richard Jelinek
BRD | Director/Board Member | 59 | 23-06-07 |
Cheryl Scott
CHM | Chairman | 74 | 15-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.80% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 29.86 | +1.19% | 646,303 |
24-04-19 | 29.51 | -0.37% | 734,826 |
24-04-18 | 29.62 | -0.07% | 827,175 |
24-04-17 | 29.64 | -1.72% | 710,339 |
24-04-16 | 30.16 | -0.46% | 881,789 |
Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.78% | 3.4B | |
+4.46% | 32.12B | |
+13.88% | 7B | |
+19.61% | 3.64B | |
-24.45% | 1.29B | |
-35.53% | 1.12B | |
+2.79% | 899M | |
-24.21% | 827M | |
-39.85% | 808M | |
-17.26% | 707M |
- Stock Market
- Equities
- EVH Stock